Company Overview

Development Stage

About the Company

[Summary] 引正基因是一家基因编辑平台技术解决方案提供商,是基因编辑平台型技术公司,专注基因编辑工具底层技术开发。公司开发的基于CRISPR的下一代基因

引正基因成立于2021年,是一家基因治疗初创公司,致力于提供安全精准、可编辑和可根治的体内基因编辑治疗解决方案(简称“DNA手术”),以填补临床治疗未能满足的需求。公司的核心研发领域包括新型Cas核酸酶基因组编辑器的发开,以及利用纳米脂质颗粒(LNP)和工程化蛋白递送载体(PDV)实现安全高效的体内递送。

公司在香港、北京和波士顿设有研究实验室和办公室。引正基因由知名生命科学投资者提供资金支持,包括启明创投、方圆资本、晟德、顺天医药、香港科技园创投基金等。

如需了解更多资讯,欢迎关注公司官网 *

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

引正基因 Financing History (6 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 戈壁大湾区Gobi GBA

引正基因 How Fast Is Hiring Growing? (5 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 65%
  • 2023: Up 92%
  • 2022: Down 8%
引正基因 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
引正基因 Campus Recruitment & Advanced Degree Talent Demand
Master's 3 Doctorate 1
Note: How fast is hiring at 北京引正基因科技有限公司 growing? 引正基因2026: 16 openings (up 100%), 2025: 8 openings (flat), 2024: 8 openings (down 65%), 2023: 23 openings (up 92%), 2022: 12 openings (down 8%), 2021: 13 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

引正基因 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 40%
  • 2024: Flat 0%-
  • 2023: Down 29%
引正基因 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 北京引正基因科技有限公司 growing? 引正基因Master's recruitment over the years: 2025: 3 openings (down 40%), 2024: 5 openings (flat), 2023: 5 openings (down 29%), 2022: 7 openings.

引正基因 Doctoral Degree Job Demand Analysis

(More)
Flat
Growth Rate
2026 vs 2025
  • 2025: Up 100%
  • 2024: Down 88%
  • 2023: Up 300%
引正基因 Doctoral Hiring by Year: 2026 — same as 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 北京引正基因科技有限公司 growing? 引正基因Doctorate recruitment over the years: 2026: 4 openings (flat), 2025: 4 openings (up 100%), 2024: 2 openings (down 88%), 2023: 16 openings (up 300%), 2022: 4 openings.

引正基因 — What Are the Salaries Like? (14 records)

Manage
salary range: 2K - 50K, 64.3% of roles pay ¥20-50K
Note: salary statistics are based on 14 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 北京引正基因科技有限公司?引正基因64.3% of positions earn 20-50K, Fresh graduate salary: ¥2.5K。质量管理类 average salary ¥18.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

引正基因 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

引正基因 Related Industry Tags

Job Category

  • 质量管理类
    37.5% of total 37.5%
  • 其他(研发和技术类)
    25% of total 25%
  • 科研类
    25% of total 25%
  • 计算机/网络/技术类
    25% of total 25%

Education

  • 硕士
    37.5% of total 37.5%
  • 本科
    25% of total 25%
  • 博士
    25% of total 25%
  • 不限
    12.5% of total 12.5%

Experience

  • 3-5年
    43.8% of total 43.8%
  • 5-10年
    37.5% of total 37.5%
  • 应届生
    6.3% of total 6.3%
  • 1-3年
    6.3% of total 6.3%
View Detailed Analysis

What does 北京引正基因科技有限公司 require? Who is 引正基因 hiring? 引正基因 recruitment: 质量管理类占比最多占37.5%,其次是其他(研发和技术类)占25%. What education can get in at 引正基因? 硕士占比最多占37.5%,其次是本科占25%. High education required at 引正基因? 硕士占37.5%,博士占25%. Work experience required at 引正基因? 3-5年占比最多占43.8%,其次是5-10年占37.5%. Where are the job locations at 引正基因? 北京占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 100万(元)
Legal Representative: 竺添
Date Established:
Credit Code: 91110114MA04DNBC2Y
Registered Address: 北京市北京经济技术开发区科创十三街18号院28号楼6层601(北京自贸试验区高端产业片区亦庄组团)

People who follow 引正基因 also follow

引正基因 Competitors (Similar Companies)

“Brand of protein reagents for target drug development”
“Large-scale pharmaceutical distribution enterprise”
“Life Sciences and Integrated Medicine”
“Decode Life, Gather Wisdom for the Public”
“A leader in the diabetes field”
“To develop high-quality biologics that are accessible and affordable f”
生物科技/生物工程 医药 生物医药 医疗科技
“Technological innovation and commercial application of pharmaceutical ”
药物研发 临床监查 医药研究 CRO
制药/药业 医药 生物医药 新药研发
“Genetic engineering pharmaceuticals, genetic engineering vaccines, and”
生物科技/生物工程 干细胞 再生医学 医学科技
“美妞出品,必属精品”
“A leader in China's pharmaceutical and healthcare market”
测序技术 肿瘤学 药物筛选 药理研究

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates